Simultaneous depletion of CD4+ and CD8+ T cells completely abrogated the therapeutic effect of ICIs plus Y33 IC, thus demonstrating that T cells are the predominant immune cells responsible for tumor rejection (online supplemental figure 11B and C). This evidence concerns the gene CD8A and neoplasm.